5-Amino-1MQ vs AOD-9604: Head-to-Head Comparison Before making a peptide selection for your research protocol, understanding the mechanistic and practical differences between 5-Amino-1MQ and AOD-9604 determines experimental validity and result interpretation
Waters et al

Published literature: Documented effects on sleep architecture and cortisol modulation in published studies Therapeutic Peptides Comparison Table Peptide Category FDA Status Primary Research Application BPC-157 Tissue Repair Category 1 (2026) Tendon, ligament, GI repair TB-500 Tissue Repair Category 1 (2026) Soft tissue, cell migration Retatrutide Metabolic Phase 3 trials Obesity, metabolic syndrome Tirzepatide Metabolic FDA-approved Type 2 diabetes, obesity Tesamorelin Metabolic / GH FDA-approved Lipodystrophy, visceral fat GHK-Cu Skin / Repair Not approved Wound healing, collagen CJC-1295 GH Secretagogue Category 1 (2026) Growth hormone release Ipamorelin GH Secretagogue Category 1 (2026) Selective GH release Selank Cognitive Category 1 (2026) Anxiety, GABA modulation Semax Cognitive Category 1 (2026) Memory, BDNF pathways KPV Anti-inflammatory Not approved Gut inflammation, skin PT-141 Neurological FDA-approved Sexual health (HSDD) SS-31 Mitochondrial FDA-approved Barth syndrome, mito dysfunction MOTS-c Mitochondrial Not approved Insulin sensitivity, exercise Humanin Cytoprotective Not approved Neuroprotection, aging DSIP Neurological Not approved Sleep regulation 2026 FDA Peptide Reclassification On February 27, 2026, HHS Secretary Robert F

The results came from a sub-analysis of the REDEFINE-1 trial and showed that cagrilintide led to significant weight loss in adults with overweight or obesity that did not have diabetes
Can you eat more with Gastric Sleeve or Gastric Bypass
Clinical data show that MHRA received 7,228 reports of gastrointestinal reactions with GLP-1 receptor agonists, whilst independent testing of unregulated peptides revealed significant purity discrepancies, with some products showing purity levels as low as 1.7% compared to supplier claims